Bridge to Life™ Expands North American Commercial Footprint with Regulatory Milestones in the U.S. and Canada- U.S. FDA grants Breakthrough Device Designation for the use of the VitaSmart® System for investigational hypothermic oxygenated perfusion of donor intestinesPR Newswire Business Technology · 2026-11-03T12:00:00.000Z